2 research outputs found
ΠΠΠΠ£ΠΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ ΠΠ‘ΠΠΠΠ’Π« ΠΠΠΠ ΠΠΠΠ―
Background: At present, convincing data on the role of immune system in pathophysiology of obesity are lacking, which makes it necessary to investigate this issue. Aim: To assess metabolic status and characteristics of immune system in patients with overweight and morbid obesity.Materials and methods: One hundred and ninety two patients with overweight and advanced obesity (mean body mass index (BMI) 36.8 Β± 7.3 kg/m. aged from 19 to 55 years) were recruited in to the study. Depending on the grade of obesity, the patients were divided into two groups. Group 1 included 84 overweight patients (BMI 27.65 Β± 0.17 kg/m.), group 2 included 88 patients with obesity grade III (BMI 44.03 Β± 0.44 kg/m.). The groups were comparable as to their age and gender. The control group comprised 20 otherwise healthy subjects with normal body weight. Assessments included parameters of carbohydrate and lipid metabolism, hemodynamic parameters, immune status including cytokine profile.Results: In patients of both groups abnormalities in carbohydrate and lipid metabolism were found, together with changes of hemodynamic parameters which were more advanced with higher degree of obesity. These parameters demonstrated that obesity promotes manifestation of metabolic syndrome. There was remarkable imbalance in pro-inflammatory cytokines. Patients with obesity grade III had a statistically significant (Ρ = 0.05) increase in their serum levels of tumor necrosis factor-Ξ± (6.32 Β± 0.49 vs 2.14 Β± 0.25), interleukin (IL)-4 (7.56 Β± 0.44 vs 1.44 Β± 0.10), IL-6 (5.39 Β± 0.89 vs 2.02 Β± 0.16), IL-17 (2.74 Β± 0.29 vs 0.59 Β± 0.20) both in basal and stimulated conditions, compared to those in patients with overweight and control patients.Conclusion: The study showed that imbalance in immune system increases with an increase of obesity grade. This imbalance implies lymphocyte maturation and differentiation, higher cytotoxicity of immunocompetent cells, over expression of receptors both to proand anti-inflammatory cytokines, apoptosis activation, abnormalities in inter-cellular cooperation and disorders of phagocytic adaptation reserve.Β ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. ΠΠ° ΡΠ΅Π³ΠΎΠ΄Π½ΡΡΠ½ΠΈΠΉ Π΄Π΅Π½Ρ ΡΠ±Π΅Π΄ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΡΠΎΠ»ΠΈ ΠΈΠΌΠΌΡΠ½Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π΅ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ ΠΎΡΡΡΡΡΡΠ²ΡΡΡ, ΡΡΠΎ ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»ΠΈΠ²Π°Π΅Ρ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΠΎ ΡΡΠΎΠΉ ΡΠ΅ΠΌΠ΅.Π¦Π΅Π»Ρ β ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΠ°ΡΡΡΠ° ΠΈ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ ΠΈΠΌΠΌΡΠ½Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΈΠ·Π±ΡΡΠΎΡΠ½ΠΎΠΉ ΠΌΠ°ΡΡΠΎΠΉ ΡΠ΅Π»Π° ΠΈ ΠΌΠΎΡΠ±ΠΈΠ΄Π½ΡΠΌ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ»ΠΈ Π²ΠΊΠ»ΡΡΠ΅Π½Ρ 192 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 19 Π΄ΠΎ 55 Π»Π΅Ρ Ρ ΠΈΠ·Π±ΡΡΠΎΡΠ½ΠΎΠΉ ΠΌΠ°ΡΡΠΎΠΉ ΡΠ΅Π»Π° ΠΈ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΌ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ (ΡΡΠ΅Π΄Π½ΠΈΠΉ ΠΈΠ½Π΄Π΅ΠΊΡ ΠΌΠ°ΡΡΡ ΡΠ΅Π»Π° (ΠΠΠ’) ΡΠΎΡΡΠ°Π²ΠΈΠ» 36,8 Β± 7,3 ΠΊΠ³/ΠΌ.). Π Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Π±ΡΠ»ΠΈ ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° Π΄Π²Π΅ Π³ΡΡΠΏΠΏΡ: Π² 1-Ρ Π³ΡΡΠΏΠΏΡ Π²ΠΎΡΠ»ΠΈ 84 Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΈΠ·Π±ΡΡΠΎΡΠ½ΠΎΠΉ ΠΌΠ°ΡΡΠΎΠΉ ΡΠ΅Π»Π° (ΠΠΠ’ 27,65 Β± 0,17 ΠΊΠ³/ΠΌ.), Π²ΠΎ 2-Ρ Π³ΡΡΠΏΠΏΡ β 88 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ III ΡΡΠ΅ΠΏΠ΅Π½ΡΡ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ (ΠΠΠ’ 44,03 Β± 0,44 ΠΊΠ³/ΠΌ.). ΠΡΡΠΏΠΏΡ Π±ΡΠ»ΠΈ ΡΠΎΠΏΠΎΡΡΠ°Π²ΠΈΠΌΡ ΠΏΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΌΡ ΠΈ ΠΏΠΎΠ»ΠΎΠ²ΠΎΠΌΡ ΡΠΎΡΡΠ°Π²Ρ. ΠΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΡΡ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 20 ΡΡΠ»ΠΎΠ²Π½ΠΎ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π»ΠΈΡ Ρ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΠΌΠ°ΡΡΠΎΠΉ ΡΠ΅Π»Π°. ΠΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ, Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π°, ΠΈΠ·ΡΡΠ°Π»ΠΈ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ, ΠΈΠΌΠΌΡΠ½Π½ΡΠΉ ΡΡΠ°ΡΡΡ, Π²ΠΊΠ»ΡΡΠ°Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠΈΠ»Ρ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΎΠ±Π΅ΠΈΡ
Π³ΡΡΠΏΠΏ ΠΎΡΠΌΠ΅ΡΠ°Π»ΠΈΡΡ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΈ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π°, ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π³Π΅ΠΌΠΎΠ΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ, Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΡ ΠΊΠΎΡΠΎΡΡΡ
ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°Π»Π°ΡΡ ΠΏΠΎ ΠΌΠ΅ΡΠ΅ Π½Π°ΡΠ°ΡΡΠ°Π½ΠΈΡ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ΠΌ, ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΡΡΠΈΠΌ ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠ°ΡΠΈΠΈ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ°. ΠΡΡΠ²Π»Π΅Π½ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΉ Π΄ΠΈΡΠ±Π°Π»Π°Π½Ρ Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ ΠΏΡΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΡΠΈΡΠΎΠΊΠΈΠ½ΠΎΠ². Π£ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ III ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠ΅ (Ρ = 0,05) ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Π΅ΠΉ ΡΠ°ΠΊΡΠΎΡΠ° Π½Π΅ΠΊΡΠΎΠ·Π° ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ-Ξ± (6,32 Β± 0,49 ΠΏΡΠΎΡΠΈΠ² 2,14 Β± 0,25), ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π°-4 (7,56 Β± 0,44 ΠΏΡΠΎΡΠΈΠ² 1,44 Β± 0,10), ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π°-6 (5,39 Β± 0,89 ΠΏΡΠΎΡΠΈΠ² 2,02 Β± 0,16), ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π°-17 (2,74 Β± 0,29 ΠΏΡΠΎΡΠΈΠ² 0,59 Β± 0,20) ΠΊΠ°ΠΊ Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ, ΡΠ°ΠΊ ΠΈ Π² ΡΠΏΠΎΠ½ΡΠ°Π½Π½ΠΎΠΌ ΠΈ Π² ΡΡΠΈΠΌΡΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΌ ΡΠΎΡΡΠΎΡΠ½ΠΈΡΡ
ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌΠΈ Ρ ΠΈΠ·Π±ΡΡΠΎΡΠ½ΠΎΠΉ ΠΌΠ°ΡΡΠΎΠΉ ΡΠ΅Π»Π°, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠΎΠΉ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π Ρ
ΠΎΠ΄Π΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π²ΡΡΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ Ρ Π½Π°ΡΠ°ΡΡΠ°Π½ΠΈΠ΅ΠΌ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Π²ΠΎΠ·ΡΠ°ΡΡΠ°Π΅Ρ Π΄ΠΈΡΠ±Π°Π»Π°Π½Ρ Π² ΠΈΠΌΠΌΡΠ½Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΠ΅, ΠΊΠΎΡΠΎΡΡΠΉ Π·Π°ΡΡΠ°Π³ΠΈΠ²Π°Π΅Ρ ΠΏΡΠΎΡΠ΅ΡΡΡ ΡΠΎΠ·ΡΠ΅Π²Π°Π½ΠΈΡ, Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²ΠΊΠΈ Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ², ΡΡΠΈΠ»Π΅Π½ΠΈΠ΅ ΡΠΈΡΠΎΡΠΎΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠΊΠΎΠΌΠΏΠ΅ΡΠ΅Π½ΡΠ½ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ, ΡΡΠΈΠ»Π΅Π½ΠΈΠ΅ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠΎΠ² ΠΊΠ°ΠΊ ΠΊ ΠΏΡΠΎ-, ΡΠ°ΠΊ ΠΈ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΌ ΡΠΈΡΠΎΠΊΠΈΠ½Π°ΠΌ, Π°ΠΊΡΠΈΠ²Π°ΡΠΈΡ Π°ΠΏΠΎΠΏΡΠΎΠ·Π°, Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² ΠΌΠ΅ΠΆΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΊΠΎΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ, Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ Π°Π΄Π°ΠΏΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΡΠ΅Π·Π΅ΡΠ²ΠΎΠ² ΡΠ°Π³ΠΎΡΠΈΡΠ°ΡΠ½ΠΎΠ³ΠΎ Π·Π²Π΅Π½Π°
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT of OBESITY and ITS COMORBIDITIES" [ΠΠΠΠΠΠ‘Π¦ΠΠΠΠΠΠΠ ΠΠ«Π ΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ Π ΠΠΠΠΠΠΠΠΠ¦ΠΠ Β«ΠΠΠ§ΠΠΠΠ ΠΠΠΠ ΠΠΠΠ― Π ΠΠΠΠΠ ΠΠΠΠΠ«Π₯ ΠΠΠΠΠΠΠΠΠΠΠΒ»]
Clinical guidelines have long been one of the working tools of the modern doctor, helping him quickly navigate the most effective proven methods of treatment and prevention of various diseases, and also to adapt these methods to the specific tasks of their patients and to achieve maximum personalization of treatment. Clinical practice guidelines are drawn up by professional non-profit associations and are approved by the Scientific Council of the Ministry of Health of the Russian Federation, while often one recommendation is prepared by two or even three associations. The peculiarity of the recommendations offered to your attention is that not only endocrinologists, but also therapists, cardiologists, gynecologists, gastroenterologists, and experts of many other specialties are involved in the prevention and treatment of obesity. The Multidisciplinary Working Group presents this a project in a multidisciplinary journal to bring together the efforts of several professional associations that associated with the need to pay attention not only to obesity itself but also to comorbid conditions. We are looking forward to constructive criticism and a comprehensive discussion of the problem on the pages of our journal. Β© 2021 Russian Association of Endocrinologists. All rights reserved